Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Clinical trial NCT01259817 · COMPLETED

Trial details

NCT number: NCT01259817
Sponsor: Ronald Hoffman
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Polycythemia Vera High Risk Essential Thrombocythemia

Start date: 2011-09-01
Primary completion: 2016-12-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.